The list of winners of the Poulsson Medal and the titles of their Poulsson lecture:
2022: Professor Roland Seifert, Institute of Pharmacology, Centre of Pharmacology and Toxicology, Hannover Medical School, Germany. “Signaling via cCMP and cUMP”
2021: Professor Åke Bergman, Örebro Universitet, Sverige. “From scientific discoveries of chemical threats to societal actions (or not) – Brominated flame retardants (BFRs), Chlorophenols (CPs), and endocrine disrupting chemicals (EDCs)”
2020: Professor Teun van Gelder, Leiden University Medical Center, The Netherlands. “Pure serendipity: a clinically relevant drug-drug interaction in organ transplantation” (Presented 2022)
2019: Professor Muthu Periasamy, UCF College of Medicine, Burnett School of Biomedical Sciences, USA. “Futile cycling of SERCA pump in muscle can melt fat and control obesity”
2018: Professor Juliette Legler, Institute for Risk Assessment Sciences (IRAS), Utrecht University, Netherlands . “Unravelling the role of environmental chemicals in disease with toxicology and epidemiology”
2017: Professor Sonia Hernandez-Diaz, Harvard T.H. Chan School of Public Health. Boston, USA. “Application of causal inference approaches in medication safety in pregnancy studies”
2016: Martin Lohse, Max Delbruck Center for Molecular Medicine, Berlin, Germany. “Receptor signaling in space and time”
2015: Professor Jan Alexander, Folkehelseinstituttet, Oslo, Norge. !Toksikologi og mattrygghet”
2014: Professor emeritus Jørg Mørland, Folkehelseinstituttet, Oslo, Norge. “Klinisk farmakologi, rettstoksikologi og rus”.
2013: Professor Thue W. Schwartz, Department of Neuroscience and Pharmacology, University of Copenhagen, Danmark. “Metabolic Receptology – Molecular, cellular and in vivo pharmacology of metabolic 7TM GPCR targets”.
2012: Professor Franz Oesch, Universitetet i Mainz, Tyskland. “Practical significance of the study of mechanisms in toxicology”.
2011: Professor Gideon Koren MD, University of Toronto, Canada. “The Motherisk Program, Toronto Hospital for Sick Children”
2010: Brian Druker (Oregon Health & Science University), “Imatinib as a Paradigm of Targeted Cancer Therapies”
2009: Professor Michael H. Depledge avd Miljø og human helse, Inst klinisk utdanning, Peninsula Medical School. “Human and environmental toxicology – two sides of the same coin?”
2008: Professor Richard M. Weinshilboum fra Mayo Clinic, Rochester, Minnesota. “Pharmacogenomics: TPMT (thiopurine methyltransferase) as a Model System”
2007: Terry Kenakin Ph.D., Molecular Discovery Research, GlaxoSmithKline. “Seven Transmembrane Receptor Drug Discovery: Putting Numbers to Shapeshifting Proteins”
2006: Professor og div. dir. dr. med Erik Dybing, “Toksikologi på Folkehelseinstituttet – før, nå og fremover”
2005: Professor og overlege Kim Brørsen, Forskningsenheden for Klinisk Farmakologi, Syddansk Universitet i Odense, Danmark: “Individualized medicince – A permanent challenge to clinical pharmacology”.
2004: Professor Anthony Pawson, Samuel Lunenfeld Research Institute, Mt. Sinai Hospital, Toronto. ” Modular protein interactions control signal transduction”.
2003: Professor Frode Fonnum, FFI Oslo: ” ”Nevrotoksikologi og cellulære mekanismer”
2002: Anders Rane, Stockholm: Pharmacogenomic variations in cytochromes P450 2B and 2C with clinical relevance in cardiovascular and oncological medicine.
2001: Prof. Peter J. Barnes, London: “New molecular mechanisms for the anti-inflammatory action of corticosteroids”.
2000: Professor Inger Nafstad, Norges Veterinærhøgskole: “Gammelt og nytt om fremmedstoffer som innvirker på fertilitet, fosterutvikling og avkom”.
1999: Professor Rune Dahlquist, Umeå. “Individualisert legemiddelbehandling – hvor nær er vi målet?
1998: Graeme Milligan, professor i molekylær farmakologi, Skottland. “Novel approaches to examine the function and desensitisation of G protein-coupled reseptors”
1997: Lars Terenius, Stockholm:
1996: Tor Nordseth, Oslo:
1995: Bertil Fredholm, Stockholm:
1994: H.P. Rang, London:
1993: Per Knut M. Lunde, Oslo:
1992: Michael J. Berridge, Cambridge: “How do cells communicate?”
1991: Helge Stormorken, Oslo: “Platehemming, antikoagulasjon og fibrinolyse”.
1990: Gerhard Zbinden, Zürich: “Alternative methods to toxicity testing”.
1989: Erik Ånggård, London: “Pharmacology of vascular endothelium”.
1988: Alasdair M. Breckendridge, Liverpool: “The future role of beta blockers in clinical medicine”.
1987: Hans Prydz, Oslo: “Tromboplastin – biokjemiske, cellebiologiske og kliniske aspekter”.
1986: Sune Rosell, Södertälje: “Utvikling av substans P (tachykinin) antagonister”.
1985: Colin Dollery, London: Clinical pharmacology of the prostacycline/thromboxane system.
1984: Sten Orrenius, Stockholm: Mekanismer för kernisk cellskada.
1983: Dr. Michal Eichelbaum, Bonn: Polymorpic Drug Oxidation in Man.
1982: Professor Alfred Gilman, University of Texas, Dallas, USA: Hormone-Sensitive Adenylate Cyclase: How Complicated can it Be?
1981: (holdt på Vintermøtet 1982) Professor Börje Uvnås: Mekanismer för upplagring och frisåtting av biogena aminer.
1980: Professor Jens Schou, København: Sikkerhetstoksikologi og produktutvikling. Hva er prisen for øket sikkerhet?
1979: Professor Leslie L. Iversen, Cambridge: Substance P and odier Neuropeptides as putative Neurotransmitters in CNS.
1978: Professor Fritz Lauterbach, Bochum, Tyskland: New Aspects Concerning the Intestinal Transport of Drugs.
1977: Professor Folke Sjöqvist, Stockholm: “Antidepressiv farmakoterapi”.
1975: (avholdt i 1976) Professor Anton Jervell, Oslo: “Medikamentell terapi gjennom 50 år slik en kliniker har opplevd utviklingen”.
1974: Professor David A. Price Evans, Liverpool: “Genetic Aspects of Drug Metabolism and Patient Response”.
1973: Professor E.J. Ariéns, Nijmegen: “Drug Design, Possibilities and Limitations”.
1972: Docent Nils Svedmyr, Göteborgs Universitet: “Bronkialmuskulaturens farmakologi relasjon til astmabehandling”.
1971: Professor Edith Billbring, University Department of Pharmacology, Oxford: “Effects of Drugs on the Adrenergic Transmission in Smooth Muscle”.
1970: Professor Bo Holmstedt, Karolinska institutet, Stockholm: “Past and present methods in drug evaluation”.
Last Updated on 22 December 2022 by Stein Bergan
